| Autor: |
Tan, S-Y, Baillod, R, Brown, E, Farrington, K, Soper, C, Percy, M, Clutterbuck, E, Madhoo, S, Pepys, MB, Hawkins, PN |
| Zdroj: |
Nephrology Dialysis Transplantation; Jun1999, Vol. 14 Issue 6, p1467-1471, 5p |
| Abstrakt: |
Background: β2-Microglobulin (β2M) amyloidosis occurs in patients with end-stage renal failure (ESRF) who undergo long-term continuous ambulatory peritoneal dialysis (CAPD), but its prevalence in patients treated exclusively by CAPD is unknown. In addition, its features may differ from those of haemodialysis-associated β2M amyloidosis because CAPD is more biocompatible. [ABSTRACT FROM PUBLISHER] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
